Aristo Pharmaceuticals Private Limited

Aristo Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1971PTC015425 Incorporated 08 November 1971 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹5,363.3 Cr
▲ 5% YoY
Net profit · FY 2025
₹1,700.65 Cr
Net margin 31.7%
EBITDA · FY 2025
₹2,361.68 Cr
EBITDA margin 44%
Authorised capital
₹99 Lakh
Registered with MCA
Paid-up capital
₹98.97 Lakh
Issued & subscribed
Satisfied charges
₹7.61 Cr
No open charges
Company age
55 yrs
Est. 1971
Employees · EPFO
9,848
Provident fund records

About Aristo Pharmaceuticals Private Limited

Data last updated:

Aristo Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 1971 and has been in existence for over 55 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1971PTC015425. Its GSTIN is 27AAACA4495N1Z8 (Maharashtra). The company holds 17 GST registrations, of which 15 are active.

The company has an authorised share capital of ₹99 Lakh and a paid-up capital of ₹98.97 Lakh. It was formerly known as Aristo Pharmaceuticals Limited. It is led by directors including Umesh Sharma (Managing Director) and Randhir Kumar Bachan (Whole-Time Director).

Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹5,363.3 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1,700.65 Cr (net margin 31.7%) and EBITDA of ₹2,361.68 Cr (EBITDA margin 44%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.

The company has about 9,848 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aristo Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹7.61 Cr on record. Court records list 285 cases involving the company, including 169 filed by the company and 116 filed against it; 75 cases are pending. The company has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹74 Lakh; the latest was in December 2020. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is MSN Laboratories Private Limited with revenue of ₹6,761.18 Cr. The company has 8 MSME Form 1 returns on record between 2019 and 2022, listing 2,203 overdue payments to 54 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aristopharma.org.

Company details

CIN U24239MH1971PTC015425
Registration Number 015425
Incorporation Date 08 November 1971
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Umesh Sharma Managing Director Randhir Kumar Bachan Whole-Time Director Virendra Sharma Director

Recognitions & Rankings of Aristo Pharmaceuticals

India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#182
Valuation
₹33,320 Cr

Contact details

Aristo Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is aristopharma.org. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    aristopharma.org
  • Social Media
  • Registered Address
    Gala No.2 Ground Floor 23 – A Shah Industrial Estate Off Veera Desai Road Andheri(West) Mum, Bai 400053, Mumbai, Maharashtra, India – 400053
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Aristo Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Aristo Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aristo Pharmaceuticals operates one associated brand: Aristo Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Aristo Pharmaceuticals
Pharmaceutical manufacturing and innovation in various therapeutic segments are conducted by Aristo Pharma.aristopharma.co.in

Business activity

The main business activity of Aristo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Aristo Pharmaceuticals Private Limited, buy the company report.

Financials of Aristo Pharmaceuticals Private Limited

FY 2025 filings available

Aristo Pharmaceuticals Private Limited reported revenue of ₹5,363.3 Cr (up 5% YoY) for FY 2025.

Revenue · FY 2025
₹5,363.3 Cr ▲ 5%
Net profit · FY 2025
₹1,700.65 Cr margin 31.7%
EBITDA · FY 2025
₹2,361.68 Cr margin 44%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 8%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 13%
5 years · compounded
▲ 18%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 5% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2,361.68 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1,700.65 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin44%
Net Profit Margin31.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aristo Pharmaceuticals Private Limited, buy the company report.

Board of directors of Aristo Pharmaceuticals Private Limited

Aristo Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Randhir Kumar Bachan
Also directs: Mapra Laboratories Pvt Ltd
Whole-Time Director01 Sep 200521 Years 1 MonthsCurrent
Virendra Sharma
Also directs: Aristo Laboratories Private Limited, Nobel Enkem Private Limited
Director03 Oct 200620 Years 0 MonthsCurrent
Umesh Sharma
Also directs: Aristo Laboratories Private Limited, Rosewell Pharmaceuticals Private Limited
Managing Director12 Feb 197947 Years 8 MonthsCurrent
View all directors

Peer comparison

Aristo Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MSN Laboratories Private Limited₹6,761.18 Cr (FY 2024)27.0%Hyderabad, Telangana, India
Alembic Pharmaceuticals Limited₹6,714.63 Cr (FY 2025)7.0%Vadodara, Gujarat, India
Abbott India Limited₹6,684.73 Cr (FY 2025)10.0%Mumbai, Maharashtra, India
Micro Labs Limited₹6,499.64 Cr (FY 2025)-2.0%Bengaluru, Karnataka, India
Aristo Pharmaceuticals Private Limitedthis company₹5,363.3 Cr (FY 2025)₹1,700.65 Cr31.7%5.0%9,848Mumbai, Maharashtra, India
Usv Private Limited₹5,202.13 Cr (FY 2025)7.0%Mumbai, Maharashtra, India
Eugia Pharma Specialities Limited₹4,828.71 Cr (FY 2025)12.0%Hyderabad, Telangana, India
Natco Pharma Limited₹4,784 Cr (FY 2025)16.0%Hyderabad, Telangana, India
Ajanta Pharma Limited₹4,742.6 Cr (FY 2025)10.0%Mumbai, Maharashtra, India
Strides Pharma Science Limited₹4,624.06 Cr (FY 2025)18.0%Thane, Maharashtra, India

To see the full peer comparison of Aristo Pharmaceuticals Private Limited, buy the company report.

Auditor

Aristo Pharmaceuticals Private Limited is audited by R.S. PRABHU & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R.S. PRABHU & ASSOCIATESFY 2024127010W

Shareholding

The shareholding of Aristo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aristo Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹7.61 Cr
Breakdown by lending institutions
State Bank of India₹5.05 Cr
Bank of India₹1.00 Cr
Srate Bank of India₹1.00 Cr
Bank of India₹0.40 Cr
State Industrial & Investment Corporation₹0.16 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Mar 199390224399Srate Bank of India₹1 CrSatisfied
08 Aug 198890220092State Bank of India₹5.05 CrSatisfied
11 Dec 198090223705Bank of India₹40 LakhSatisfied
14 Nov 198090223702Bank of India₹40 LakhSatisfied
10 Mar 197990223681Bank of India₹53 LakhSatisfied

To see the full charge records of Aristo Pharmaceuticals Private Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Aristo Pharmaceuticals Private Limited has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹74 Lakh; the latest was in December 2020.

Total deals
10
Secondary share transfers
9
Funding round
1
Disclosed funding
₹74 Lakh

Deals on record (5 of 10)

WhenDealAmountParties
Dec 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Aug 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Dec 2017Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jun 2017Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2016Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals

To see the full deal history of Aristo Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Aristo Pharmaceuticals Private Limited has 8 MSME Form 1 returns on record between 2019 and 2022, listing 2,203 overdue payments to 54 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 54)

SupplierAmount dueDue sinceReported on
Mak Polyplast Private Limited
A.R.Pharma Packaging Private Limited
Adit Pharma Private Limited
Himalayan Capscon Industries
KC Overseas Private Limited

To see the full MSME payment records of Aristo Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Aristo Pharmaceuticals Private Limited has a workforce of 9,848 employees on its EPFO records as of Feb 17, 2025, across 1 active EPFO establishment.

Employee count
9,848
Active EPFO establishments
1
Employee growth
8.75%

GST

Aristo Pharmaceuticals has 17 GST registrations: 15 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
17
Active
15
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAACA4495N1Z8MaharashtraActive01 Jul 2017
02AAACA4495N1ZKHimachal PradeshActive01 Jul 2017
04AAACA4495N1ZGChandigarhActive01 Jul 2017
06AAACA4495N1ZCHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Aristo Pharmaceuticals Private Limited, buy the company report.

Recent activity

Aristo Pharmaceuticals Private Limited has 7 board changes on record since 1979: 3 appointments and 4 cessations. The latest: Raj Nandan Sharma ceased to be Director on 21 Sep 2017.

AGM
Aristo Pharmaceuticals Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Filing
Aristo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 11 Dec 1980 via Charge ID 90223705 with Bank Of India was fully satisfied on 06 Dec 2023.
Charges
A charge registered on 14 Nov 1980 via Charge ID 90223702 with Bank Of India was fully satisfied on 06 Dec 2023.
Charges
A charge registered on 10 Mar 1979 via Charge ID 90223681 with Bank Of India was fully satisfied on 06 Dec 2023.
Charges
A charge registered on 25 Feb 1974 via Charge ID 90223630 with Bank Of India was fully satisfied on 06 Dec 2023.
Charges
A charge registered on 29 Nov 1972 via Charge ID 90223621 with Bank Of India was fully satisfied on 06 Dec 2023.
Charges
A charge registered on 08 Aug 1988 via Charge ID 90220092 with State Bank Of India was fully satisfied on 14 Aug 2023.
Charges
A charge registered on 27 Feb 1974 via Charge ID 90223631 with State Industrial & Investment Corporation was fully satisfied on 17 Jul 2023.
Ceased
Raj Nandan Sharma ceased to be Director.
Charges
A charge registered on 04 Mar 1993 via Charge ID 90224399 with Srate Bank Of India was fully satisfied on 23 Dec 2015.
Ceased
Ranjit Sharma ceased to be Director.

15 earlier events are in the company report.

Frequently asked questions

Aristo Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 1971 (55+ years old) and is registered under CIN U24239MH1971PTC015425.

Aristo Pharmaceuticals has 3 current directors:

The latest financial statements of Aristo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Aristo Pharmaceuticals is 27AAACA4495N1Z8, registered in Maharashtra. The company has 17 GST registrations in all, of which 15 are active and 2 are cancelled or inactive. Other active GSTINs include 02AAACA4495N1ZK (Himachal Pradesh), 04AAACA4495N1ZG (Chandigarh), 06AAACA4495N1ZC (Haryana).

The CIN (Corporate Identification Number) of Aristo Pharmaceuticals is U24239MH1971PTC015425. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aristo Pharmaceuticals has 285 court cases on record: 169 filed by the company and 116 filed against it. 75 are pending. Most are in the high courts.

Aristo Pharmaceuticals was incorporated on 08 November 1971, making it 55+ years old. It is registered with the Registrar of Companies, Mumbai.

Aristo Pharmaceuticals has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹74 Lakh; the latest was in December 2020.

The peers of Aristo Pharmaceuticals by revenue are MSN Laboratories Private Limited, Alembic Pharmaceuticals Limited, Abbott India Limited, Micro Labs Limited, Usv Private Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Raj Nandan Sharma ceased to be Director on 21 Sep 2017. Ranjit Sharma ceased to be Director on 23 Jun 2011. Devinder Rai ceased to be Director on 22 May 2008. Aristo Pharmaceuticals has 7 board changes on record in total.

Aristo Pharmaceuticals has 8 MSME Form 1 returns on record between 2019 and 2022, listing 2,203 overdue payments to 54 micro and small suppliers. The latest return was filed on 13 Sep 2023.

Aristo Pharmaceuticals can be reached through the website aristopharma.org. Its registered office is in Mumbai, Maharashtra, India.